EUCTR2014-004590-16-NL进行中（未招募）不适用
18F-Choline PET/CT for patients with primary hyperparathyroidism and negative SPECT/CT - PHPPET study
MC Utrecht0 个研究点开始时间: 2015年1月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Patients who have signed informed consent
- •-Age = 18 years
- •-Biochemically proven PHP
- •-Indication for surgery
- •-Negative SPECT/CT
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 8
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 2
排除标准
- •-Pregnancy
- •-Patients with MEN syndrome
研究者
相似试验
已完成
不适用
18F-Choline PET/CT for patients with primary hyperparathyroidism and negative SPECT/CTprimary hyperparathyroidismoverproduction Parathyroid Hormone10033949NL-OMON40137niversitair Medisch Centrum Utrecht10
进行中（未招募）
1 期
Diagnostic value of 18F-choline PET in patients with indeterminate cytology thyroid nodule : A pilot studyPatient with a thyroid nodule =15mm with indefinite cytology according to the 2008 Bethesda classification (vesicular lesion of undetermined significancefollicular neoplasm or cell Hürthlelesion suspicious for malignancy), and to be operatedMedDRA version: 19.0 Level: HLT Classification code 10043747 Term: Thyroid neoplasms System Organ Class: 100000004860EUCTR2015-005017-71-FRCentre François Baclesse135
尚未招募
不适用
se of the PET/CT [18F]-Fluorocholine: Diagnostics and Follow-up of Hepatocellular Carcinomahepatocellular carcinomalivercancer1001981510019818NL-OMON36749Academisch Medisch Centrum100
进行中（未招募）
1 期
Prospective comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the initial work-up of Multiple MyelomaMultiple myelomaMedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864EUCTR2018-003926-10-FRCHU de Bordeaux30
进行中（未招募）
1 期
Diagnostic value of 18F-choline PET/CT for the detection of systemic prostate cancer disease. - 2008-CaP-FCHde novo patients with histologically confirmed prostate cancerMedDRA version: 12.0Level: LLTClassification code 10060862Term: Prostate cancerEUCTR2009-014839-21-FRCIS bio international, member of IBA group150